#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cushing's syndrome Pemphigoid Corneal neovascularisation Retinal dystrophy Germ cell cancer Huntington's disease Acute myeloid leukaemia (in remission) Familial haemophagocytic lymphohistiocytosis Cutaneous T-cell lymphoma refractory Breast angiosarcoma Epileptic encephalopathy Glycogen storage disease type V Transferrin decreased Subdural haematoma Immunodeficiency congenital More trials…

    Learn about Rare Diseases

    Cytokine release syndrome – Trials in Disease Osteosarcoma metastatic – Diagnostics Malignant fibrous histiocytoma – Trials in Disease Malignant fibrous histiocytoma – Life with Disease Cholangitis sclerosing – Basic Information Mantle cell lymphoma Rhabdoid tumour – Diagnostics Factor IX deficiency – Diagnostics Mantle cell lymphoma – Basic Information Hereditary optic atrophy – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Tepotinib Nirmatrelvir Clobetasol Ferric Carboxymaltose Ampicillin Sodium Dactylis Glomerata AZD6234 Ixekizumab Insulin Icodec Levoleucovorin Benzalkonium Chloride Levobupivacaine Syn321 Bio89-100 Neratinib Phenylephrine Varenicline Nadunolimab Norfloxacin Anastrozole More therapies…

    Learn about Your Condition

    Short-bowel syndrome Lower limb fracture Thrombocytopenia Inflammation Noninfective chorioretinitis Vulvar dysplasia Liposarcoma metastatic Dry mouth Diabetic retinopathy Breast cancer in situ Endometrial cancer recurrent Glanzmann's disease Fontan procedure Prolymphocytic leukaemia Choroidal neovascularisation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Effects of Siponimod for Patients with Secondary Progressive Multiple Sclerosis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Siponimod
    Italy

  • Study on Darbepoetin Alfa for Reducing Brain Injury in Newborns with Perinatal Arterial Ischemic Stroke

    Recruiting

    2 1 1
    Investigated Diseases:
    • Ischaemic stroke
    Investigated Drugs:
    • Darbepoetin Alfa
    The Netherlands

  • Study on the Effects of Nadroparin Calcium in Patients with Subarachnoid Hemorrhage

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Subarachnoid haemorrhage
    Investigated Drugs:
    • Nadroparin Calcium
    The Netherlands

  • Study on the Effects of Low-Dose Acetylsalicylic Acid in Patients with Bipolar Disorder

    Recruiting

    2 1 1
    Investigated Diseases:
    • Bipolar disorder
    Investigated Drugs:
    • Acetylsalicylic Acid
    Poland

  • Study on Human Fetal Neural Precursor Cells and Tacrolimus for Patients with Progressive Multiple Sclerosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Progressive multiple sclerosis
    Investigated Drugs:
    • Human Neuronal Progenitor/Stem Cells
    • Tacrolimus
    Italy

  • Study of ADS-010 for Adults with Facioscapulohumeral Muscular Dystrophy Type 1

    Recruiting

    2 1 1
    Investigated Diseases:
    • Facioscapulohumeral muscular dystrophy
    Investigated Drugs:
    • Ads-010
    • Sodium Chloride
    Germany Italy The Netherlands Spain
Previous Page
1 … 29 30 31 32 33 … 141
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!